SAQ Flashcards
3 Main drug categories of antibiotics
Inhibition cell wall synthesis
Inhibition protein synthesis
Inhibition DNA synthesis & Nucleic acid
2 Drugs inhibiting cell wall synthesis
+ w examples
1) Beta-lactams (Penincillin, Cephalosporin)
2) Glycopeptides (Vancomycin, Teicoplanin)
How does betalactams and glycopeptides inhibit cell wall synthesis?
•Beta-lactams bind to and inhibit penicillin-binding proteins (PBPs), which are crucial for peptidoglycan cross-linking, disrupting cell wall integrity and leading to bacterial cell lysis.
•Glycopeptides bind to the terminal D-Ala-D-Ala moiety of peptidoglycan precursors, preventing cell wall synthesis and resulting in bacterial cell death.
Name 3 Drug classes that inhibit 50s protein synthesis
+examples
•Macrolides (azi,ery,clari,roxy -thromycin)
•Lincosamides (clindamycin)
•Oxazolidinones (line, tedi -zolid)
Name 2 Drug classes that inhibit 30s protein synthesis
+examples
Aminoglycosides (gentamicin, Neo&tobra mycin)
Tetracyclines (Doxy, mino, tige -cyclines)
Name 2 drug classes that inhibit DNA synthesis and their examples.
•Quinolones (Ciprofloxacin)
•Sulfonamides (Sulfamthoxazole, sulfadiazine)
MOA of quinolones & sulfonamides
•Quinolones inhibit DNA gyrase and topoisomerase IV, enzymes necessary for bacterial DNA replication, leading to DNA strand breaks and cell death.
•Sulfonamides inhibit dihydropteroate synthase, an enzyme involved in the synthesis of folic acid, which is necessary for DNA and RNA synthesis in bacteria.
List three quinolone antibiotics and their primary clinical indications.
•Ciprofloxacin (urinary tract infections)
•Levofloxacin (respiratory infections)
•Moxifloxacin (community-acquired pneumonia)
Name two sulfonamide antibiotics and their therapeutic use.
Answer:
•Sulfamethoxazole (used with trimethoprim for urinary tract infections),
•Sulfadiazine (used in combination with pyrimethamine for toxoplasmosis).
List Common AE of beta-lactam drugs
GI upset: Nausea, Diarrhea, Vomiting
Potential adverse effects of glycopeptides, and how can they be mitigated?
•Nephrotoxicity
•Redman syndrome
•To mitigate, monitor renal function and slow infusion rate
AE of Tetracyclines
Cramps, nausea, diarrhea
Tooth discoloration
Enamel hypoplasia
A 45-year-old male patient is started on Vancomycin for a methicillin-resistant Staphylococcus aureus (MRSA) infection. After the first infusion, he develops erythema and pruritus over his upper body and face. What is the likely cause of these symptoms, and how should the infusion be adjusted?
Answer:
The patient is experiencing Redman syndrome, a reaction associated with rapid Vancomycin infusion due to histamine release. The infusion should be slowed, and antihistamines can be administered if necessary.
A 30-year-old patient presents with recurrent urinary tract infections and is prescribed Ciprofloxacin. Which enzyme does Ciprofloxacin target, and what are the possible adverse effects to monitor for?
Answer:
Ciprofloxacin targets DNA gyrase and topoisomerase IV. Adverse effects include gastrointestinal upset, tendonitis, and the risk of tendon rupture.
A 60-year-old patient with a history of renal impairment is being treated for a serious Gram-positive bacterial infection. Which antibiotic class should be used with caution due to the risk of nephrotoxicity, and what adjustments should be made?
Answer:
Glycopeptides (e.g., Vancomycin) should be used with caution due to nephrotoxicity. Dose adjustments based on renal function and close monitoring of serum levels are recommended to avoid toxicity.